Fludarabine phosphate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2072 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Myeloid leukemia acute	D015470	—	C92.0	141	210	47	5	23	365
Myelodysplastic syndromes	D009190	—	D46	109	221	20	2	25	332
Leukemia	D007938	—	C95	87	166	20	2	23	255
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	103	146	16	5	18	249
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	81	142	25	3	12	232
Non-hodgkin lymphoma	D008228	—	C85.9	99	121	9	1	17	209
Lymphoma	D008223	—	C85.9	63	104	8	1	19	173
Myeloproliferative disorders	D009196	—	D47.1	15	32	3	1	7	51
Graft vs host disease	D006086	—	D89.81	14	30	2	1	2	42
Beta-thalassemia	D017086	Orphanet_848	D56.1	2	5	—	2	1	9

Show 1 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Multiple myeloma	D009101	—	C90.0	84	100	9	—	17	186
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	26	89	5	—	11	116
Hodgkin disease	D006689	—	C81	36	73	3	—	13	109
Neoplasms	D009369	—	C80	67	38	1	—	5	90
Melanoma	D008545	—	—	46	56	1	—	2	88
Hematologic neoplasms	D019337	—	—	31	57	1	—	13	86
Follicular lymphoma	D008224	—	C82	32	45	9	—	5	82
Mantle-cell lymphoma	D020522	—	C83.1	35	44	7	—	5	78
Large b-cell lymphoma diffuse	D016403	—	C83.3	41	39	3	—	4	73
Aplastic anemia	D000741	HP_0001915	D61.9	10	37	4	—	11	52

Show 31 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
B-cell lymphoma	D016393	—	—	43	19	—	—	3	60
Plasma cell neoplasms	D054219	—	—	14	30	—	—	6	46
Ovarian neoplasms	D010051	EFO_0003893	C56	29	21	—	—	—	39
Breast neoplasms	D001943	EFO_0003869	C50	20	20	—	—	—	31
Biphenotypic leukemia acute	D015456	—	C95.0	15	18	—	—	—	30
B-cell lymphoma marginal zone	D018442	—	C88.4	10	17	—	—	5	29
Myelomonocytic leukemia juvenile	D054429	—	C93.3	7	17	—	—	3	24
Neuroblastoma	D009447	EFO_0000621	—	16	10	—	—	—	23
Kidney neoplasms	D007680	EFO_0003865	C64	10	17	—	—	2	23
Renal cell carcinoma	D002292	EFO_0000376	—	18	10	—	—	1	22

Show 197 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Castration-resistant prostatic neoplasms	D064129	—	—	5	—	—	—	—	5
Carcinoma	D002277	—	C80.0	4	—	—	—	—	4
Ovarian epithelial carcinoma	D000077216	—	—	4	—	—	—	—	4
Wilms tumor	D009396	EFO_0000212	—	3	—	—	—	—	3
Squamous cell carcinoma of head and neck	D000077195	—	—	3	—	—	—	—	3
Small cell lung carcinoma	D055752	—	—	2	—	—	—	—	2
Ependymoma	D004806	—	—	2	—	—	—	—	2
Primitive neuroectodermal tumors	D018242	—	—	2	—	—	—	—	2
Rhabdoid tumor	D018335	—	—	2	—	—	—	—	2
Lymphatic diseases	D008206	HP_0100763	—	2	—	—	—	—	2

Show 36 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Plasmacytoma	D010954	—	C90.3	—	—	—	—	2	2
Aids-related lymphoma	D016483	EFO_1001365	—	—	—	—	—	1	1
Chronic kidney failure	D007676	EFO_0003884	N18.6	—	—	—	—	1	1